The association of remdesivir and in-hospital outcomes for COVID-19 patients treated with steroids.

Toshiki KunoYoshihisa MiyamotoMasao IwagamiMiho IshimaruMai TakahashiNatalia N Egorova

Published in: The Journal of antimicrobial chemotherapy (2021)

Remdesivir was not associated with reduced risk of in-hospital mortality in patients with COVID-19 treated with steroids but potentially associated with decreased risk of AKI. These findings should be confirmed in prospective studies focusing on COVID-19 patients treated with steroids.

Keyphrases

coronavirus disease
sars cov
acute kidney injury
healthcare
respiratory syndrome coronavirus
emergency department
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
adverse drug
newly diagnosed
insulin resistance
glycemic control
drug induced